OakChart

InfuSystem Holdings Inc

INFUHealthcare·Medical Devices·USA·Small·AMEX·Nov 11 • 3:59 PM ET

15.08-0.20 (-1.31%)
2026-11-12 02:54 CET
Market cap
300.35 USD m
Revenue, TTM
144.44 USD m
Net income, TTM
9.44 USD m
Free cash flow, TTM
24.76 USD m
EPS diluted, TTM
0.45
P/E
33.55
Compare

Price

INFU against its 20, 50 and 200-day averages
2050200beat
8.0010.0012.0014.001.4M2.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26INFUclose 15.0820-day 14.0150-day 13.28200-day 10.5515.0852w high

2.5% under the 52-week high of 15.47 on 11 Nov 2026. 52-week low 7.29 on 2 Mar 2026. Last 15 sessions, 25.4% high to low

Volume 1.54× normal · the line is the 50-bar volume average

Profile

INFU
52-week range, 97% of the way up
7.2915.32

InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.

IndexRUT
Employees473
IPOJun 15, 2006
Beta1.37
ATR, 14d0.68
Rel volume1.54
Short float3.61%
Insider own5.61%
Inst own78.54%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap302.10M
Enterprise Value315.49M
Income9.44M
Sales144.44M
Book/sh3.20
Cash/sh0.45
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees473
IPOJun 15, 2006

Ratios

P/E33.55
Forward P/E24.72
PEG0.86
P/S2.09
P/B4.71
P/C33.16
P/FCF12.20
EV/EBITDA11.64
EV/Sales2.18
Quick Ratio2.39
Current Ratio2.68
Debt/Eq0.35
LT Debt/Eq0.35
Option/ShortYes / Yes

Earnings

EPS (ttm)0.45
EPS next Y0.61
EPS next Q0.14
EPS this Y59.14%
EPS next Y23.65%
EPS next 5Y28.65%
EPS past 3/5Y632.25% -17.01%
Sales past 3/5Y9.28% 8.05%
EPS Y/Y TTM76.01%
Sales Y/Y TTM2.40%
EPS Q/Q38.96%
Sales Q/Q3.02%
EarningsNov 05 BMO
EPS/Sales Surpr.15.38% 0.82%

Ownership

Insider Own5.61%
Insider Trans1.36%
Inst Own78.54%
Inst Trans4.43%
ROA9.28%
ROE15.78%
ROIC10.89%
Gross Margin56.29%
Oper. Margin9.83%
Profit Margin6.54%
SMA207.61%
SMA5013.55%
SMA20042.99%
Trades-

Technical

Shs Outstand20.03M
Shs Float18.91M
Short Float3.61%
Short Ratio5.33
Short Interest0.68M
52W High15.32 -1.60%
52W Low7.29 106.86%
Volatility5.94% 4.80%
ATR (14)0.68
RSI (14)64.20
Beta1.37
Rel Volume1.54
Avg Volume128.24K
Volume198,031

Performance

Perf Week14.68%
Perf Month11.79%
Perf Quarter20.83%
Perf Half Y83.68%
Perf YTD68.12%
Perf Year44.31%
Perf 3Y75.55%
Perf 5Y-8.83%
Perf 10Y693.68%
Recom1.00
Target Price18.50
Prev Close15.28
Price15.08
Change %-1.31%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Sep 22, 2025ResumedLLake StreetBuy$15-0.5%
Jul 22, 2025InitiatedRRoth CapitalBuy$12-20.4%
Sep 26, 2024InitiatedRB. Riley SecuritiesBuy$13-13.8%
Apr 26, 2021InitiatedNNorthland CapitalOutperform$27+79.0%
Dec 29, 2020InitiatedSSidotiBuy$26+72.4%
Aug 31, 2020InitiatedCCraig HallumBuy$28+85.7%
Jun 09, 2020InitiatedLLake StreetBuy$17+12.7%

Peers

Mkt cap
TickerCompanyMkt cap
VMDViemed Healthcare Inc345.96M
AHCOAdaptHealth Corp1.06B
ICUIICU Medical Inc4.46B
ELMDElectromed Inc206.84M
OPCHOption Care Health Inc4.75B
INGNInogen Inc149.51M
BAXBaxter International Inc13.63B
TCMDTactile Systems Technology Inc607.74M
BDXBecton Dickinson & Co58.43B
UTMDUtah Medical Products Inc208.06M

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Funke JerodEVP-Chief HR OfficerOct 09 '26Option Exercise0.007,157036,811Oct 13 07:43 PM
Steele Barry GExecutive VP and CFOMay 18 '26Option Exercise0.008,7150121,567May 19 09:48 PM
Steele Barry GExecutive VP and CFOMay 16 '26Option Exercise0.007,5110104,101May 19 09:48 PM
Funke JerodEVP-Chief HR OfficerMay 16 '26Option Exercise0.005,183023,845May 19 09:48 PM
Lachance CarriePresident and CEOMay 18 '26Option Exercise0.008,9320269,906May 19 09:48 PM
Lachance CarriePresident and CEOMay 16 '26Option Exercise0.0010,4180248,541May 19 09:48 PM
Chupa AddamExecutive VP and CIOMay 18 '26Option Exercise0.005,447063,154May 19 09:48 PM
Chupa AddamExecutive VP and CIOMay 16 '26Option Exercise0.004,375051,585May 19 09:48 PM
GENDRON PAUL ANDREWDirectorMay 08 '26Buy8.885,00044,40070,000May 12 09:31 AM
Lachance CarriePresident and CEOMay 08 '26Buy8.832,00017,660237,123May 12 09:29 AM
Lachance CarriePresident and CEOMay 11 '26Buy8.461,0008,460238,123May 12 09:29 AM
Steele Barry GExecutive VP and CFOMay 08 '26Buy8.717,00060,94996,590May 12 09:27 AM
Steele Barry GExecutive VP and CFOMar 02 '26Buy9.162,06418,90688,000Mar 02 06:53 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1500.1300.15037.5937.283
2026Q22026-08-040.1500.1050.15436.9336.354
2026Q12026-05-070.0500.0330.04933.6834.334
2025Q42026-02-240.1000.0720.09736.2336.685
2025Q32025-11-040.1100.0800.10836.4936.815
2025Q22025-08-050.1200.0360.12336.0036.115
2025Q12025-05-08-0.010-0.030-0.01334.7233.774
2024Q42025-03-040.0400.0750.04333.8534.904
2024Q32024-11-070.0800.0630.08335.3234.484
2024Q22024-08-080.0300.0370.03333.7033.173
2024Q12024-05-09-0.0500.020-0.05232.0032.003
2023Q42024-03-140.0100.0030.00331.7730.003
2023Q32023-11-070.0300.0270.03231.9130.773
2023Q22023-08-030.0200.0030.02031.7429.103
2023Q12023-05-04-0.0200.020-0.01630.3728.833
2022Q42023-03-150.0100.0430.00528.8330.803

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2014FY0.1500.1500.15066.49-
2015FY0.231-0.12072.13-
2019FY0.070-0.06581.10-
2020FY0.8000.3970.79897.3996.83
2021FY0.0600.1470.064102.38106.75
2022FY0.0000.0430.001109.91111.87
2023FY0.0400.0400.040125.79124
2024FY0.1100.1430.108134.86135.93
2025FY0.3100.2900.310143.44143.88
2026FY-0.493--145.48
2027FY-0.610--154.04
2028FY-0.660--162

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0530037.2737.0037.41
2026Q4S2026-11-0330037.2737.0037.41
2026Q4S2026-08-2730037.2737.0037.41
2026Q4S2026-08-0440037.3337.0037.50
2026Q4S2026-07-2140037.4737.0037.80
2026Q4S2026-05-1041037.4737.0037.80
2026Q4S2026-05-0741337.4737.0037.80
2026Q4S2026-05-0640437.3237.0037.69
2026Q4S2026-02-2450437.3837.0037.69
2026Q4S2026-01-1850038.6637.8040.00
2026Q4S2025-11-1150438.6637.8040.00
2026Q4S2025-11-1050438.6637.8040.00
2026Q4S2025-11-0950438.6637.8040.00
2026Q4S2025-11-0850438.6637.8040.00

Estimate history

EPS, annual-0.911-0.0510.0650.7980.0640.0010.040.1080.3140.4495
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0830.043-0.0130.1230.1080.0970.0490.1540.15
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual71.07767.13881.11597.388102.382109.914125.785134.861143.436144.44
Period201720182019202020212022202320242025TTM
Sales, quarterly35.3233.84834.71636.00236.48836.2333.68436.93337.589
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual22.78119.57719.88220.29820.720.78221.19721.27220.2120.028
Period201720182019202020212022202320242025MRQ
Shares, quarterly21.23421.27220.97420.42620.32720.2120.17919.91420.028
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue144.44143.44134.86125.78109.91102.3897.3981.1167.14
Cost of Goods Sold Incl. D&A63.1465.2666.7564.7752.9547.3543.7139.1333.17
Gross Profit81.3078.1868.1161.0256.9755.0353.6741.9833.97
Selling, General and Administrative Excl. Other67.0966.2661.2256.9355.3152.0244.8537.9333.18
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income14.2011.926.894.091.653.028.834.050.79
Interest Expense1.431.802.472.911.601.271.251.901.42
Unusual Expense0.000.000.000.000.000.200.000.520.37
Net Income Before Taxes13.3310.625.061.850.131.267.541.52-1.04
Income Taxes3.894.002.710.980.11-0.16-9.790.160.05
Consolidated Net Income9.446.632.350.870.021.4217.331.36-1.09
Net Income From Continuing Operations9.446.632.350.870.021.4217.331.36-1.09
Net Income9.446.632.350.870.021.4217.331.36-1.09
EPS (Recurring)0.450.310.110.040.000.070.800.08-0.04
EPS (Basic, Before Extraordinaries)0.470.320.110.040.000.070.860.07-0.05
EPS (Diluted)0.450.310.110.040.000.060.800.07-0.05
EBITDA27.1025.2119.3916.6015.0117.6422.8516.3912.10
Non-Operating Income (Expense)0.560.510.640.670.08-0.29-0.03-0.10-0.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.943.603.983.032.976.401.910.730.76
Price To Earnings Ratio33.5533.55125.37255.21700.00269.8923.56137.36-
Price To Sales Ratio1.881.321.361.811.703.674.192.191.10
Gross Margin56.2954.5050.5148.5151.8353.7555.1151.7550.60
Operating Margin9.838.315.113.251.502.959.064.991.17
Net Margin6.544.621.740.690.021.3917.801.68-1.63
Shares Outstanding20.0320.2121.2721.2020.7820.7020.3019.8819.58
Market Capitalization300.35300.35179.68223.27179.30351.66380.05169.2667.22

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue37.5936.9333.6836.2336.4936.0034.7233.85
Cost of Goods Sold Incl. D&A16.3315.9914.5116.3116.1816.6816.1016.28
Gross Profit21.2620.9419.1719.9220.3119.3318.6217.57
Selling, General and Administrative Excl. Other16.5216.7917.5816.2116.5015.5518.0014.95
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income4.754.151.593.713.813.780.622.62
Interest Expense0.360.350.350.380.460.500.470.51
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes4.543.871.423.503.433.450.252.26
Income Taxes1.390.640.401.461.170.850.521.33
Consolidated Net Income3.163.231.022.042.262.60-0.270.93
Net Income From Continuing Operations3.163.231.022.042.262.60-0.270.93
Net Income3.163.231.022.042.262.60-0.270.93
EPS (Recurring)0.150.150.050.100.110.12-0.010.04
EPS (Basic, Before Extraordinaries)0.160.160.050.100.110.12-0.010.04
EPS (Diluted)0.150.150.050.100.110.12-0.010.04
EBITDA7.877.334.847.067.097.123.946.04
Non-Operating Income (Expense)0.150.070.180.160.080.170.100.16
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.980.980.971.001.040.520.880.94
Price To Earnings Ratio33.5523.6824.5134.2943.6842.5150.28125.37
Price To Sales Ratio1.881.411.351.321.540.940.831.36
Gross Margin56.5656.6956.9254.9955.6553.6853.6351.90
Operating Margin12.6311.244.7210.2510.4410.491.787.73
Net Margin8.408.753.025.626.197.22-0.772.76
Shares Outstanding20.0319.9120.1820.2120.3320.4320.9721.27
Market Capitalization300.35194.75186.59182.42211.61130.89113.03179.68

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments3.190.530.230.170.199.652.654.323.47
Short Term Receivables22.9021.1619.8316.8715.4014.7212.109.5911.28
Inventories5.396.536.404.823.943.002.902.251.76
Other Current Assets4.863.964.162.922.542.401.661.371.15
Total Current Assets36.3432.1630.6224.7822.0729.7719.3017.5417.67
Net Property, Plant & Equipment7.549.4011.028.558.7644.3742.9924.9325.00
Total Investments and Advances39.7943.8139.4244.2041.970.000.000.000.00
Long-Term Note Receivable1.340.731.520.00-----
Intangible Assets10.5810.1711.1612.1514.6411.1815.4619.8624.51
Deferred Tax Assets13.1414.4616.0916.4814.449.97--0.00
Other Assets0.340.150.070.080.121.711.461.741.70
Total Assets109.06110.88109.89106.24101.9996.9979.2264.0768.88
Short Term Debt Incl. Current Port. of LT Debt1.391.481.470.001.359.429.494.943.54
Accounts Payable10.829.858.018.347.866.787.967.095.52
Other Current Liabilities7.976.336.236.133.696.794.392.763.41
Total Current Liabilities20.1817.6615.7114.4712.9023.0021.8514.7912.47
Long Term Debt23.0528.4234.9036.9236.4233.2434.9428.8425.39
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities8.507.276.976.864.40-0.10-0.06
Other Liabilities0.000.000.000.000.000.000.000.000.01
Total Liabilities51.7353.3557.5858.2453.7256.2456.8943.6337.93
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity57.3357.5352.3048.0048.2740.7522.3320.4430.95
Total Shareholders Equity57.3357.5352.3048.0048.2740.7522.3320.4430.95
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity57.3357.5352.3048.0048.2740.7522.3320.4430.95
Total Liabilities & Stockholders Equity109.06110.88109.89106.24101.9996.9979.2264.0768.88
Book Value Per Share2.842.702.472.312.332.011.121.041.36
Tangible Book Value Per Share2.312.231.941.731.621.460.350.030.28
Full-Time Employees473514516438407292269251245
Price to Book Ratio4.713.234.343.757.309.357.593.291.07
Return on Assets6.032.120.810.021.4319.671.90-1.65-24.10
Return on Equity11.544.271.740.043.1954.956.36-4.26-50.73
Return on Invested Capital8.242.731.000.021.6823.422.38-2.22-36.75
Quick Ratio1.531.451.541.381.411.160.751.031.27
Current Ratio1.801.821.951.711.711.290.881.191.42

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income9.446.632.350.870.021.4217.331.36-1.09
Depreciation12.9013.2912.5012.5113.3614.6214.0312.3411.31
Other Funds (Non Cash)5.431.853.042.543.735.120.260.266.19
Funds from Operations30.3924.5019.8116.5617.1321.0121.5514.0616.34
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-5.17-0.090.65-5.560.39-2.69-1.26-0.19-4.95
Cash from Operating Activities25.2224.4120.4610.9917.5218.3220.2813.8811.39
Capital Expenditures-0.45-0.56-1.09-1.02-0.98-16.66-16.91-22.59-8.30
Net Assets From Acquisitions0.00-1.410.000.000.00-7.980.000.00-
Sale of Fixed Assets and Businesses2.013.314.594.383.603.324.752.953.32
Purchase or Sale of Investments-11.50-8.13-16.74-10.09-14.090.000.000.000.00
Purchase of Investments-11.50-8.13-16.74-10.09-14.090.000.000.000.00
Sale Or Maturity of Investments-0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-9.95-6.79-13.24-6.73-11.48-21.32-12.16-19.64-4.98
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-5.79-10.64-1.61-0.25-5.30-0.61-1.52-0.47-10.37
Repurchase of Common Pref Stock-7.14-10.97-2.00-1.31-6.65-1.73-1.71-0.72-10.46
Sale of Common Pref Stock1.340.340.391.061.351.120.190.250.09
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.250.00
Issuance or Reduction of Debt, Net-1.33-4.32-5.32-3.95-0.01-5.860.414.564.82
Change in Long Term Debt-1.33-4.32-5.32-3.95-0.01-5.850.414.564.82
Issuance of Long Term Debt23.5048.0350.8051.5542.0275.8137.599.4311.13
Reduction of Long Term Debt-24.83-52.35-56.11-55.50-42.03-81.66-37.18-4.87-6.32
Net Financing Active Other Cash Flow0.000.000.000.00-0.750.000.000.000.00
Other Financing Activities Uses0.000.000.000.00-0.750.000.000.000.00
Cash from Financing Activities-7.12-14.96-6.92-4.19-6.06-6.46-1.124.10-5.56
Net Change in Cash8.152.660.300.07-0.02-9.467.00-1.670.85
Free Cash Flow24.7623.8519.379.9716.541.663.37-8.723.09
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow10.977.949.4722.8811.31226.21121.17-23.86
Deferred Taxes & Investment Tax Credit-2.731.920.630.02-0.15-10.070.10-0.06

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments9.110.962.113.190.950.72
Short Term Receivables29.5527.2023.9822.9024.3124.48
Inventories5.155.525.835.395.595.67
Other Current Assets4.104.584.744.864.723.93
Total Current Assets47.9138.2736.6636.3435.5734.80
Net Property, Plant & Equipment6.386.527.067.548.178.68
Total Investments and Advances36.5337.6138.6939.7939.0440.12
Intangible Assets10.0310.1910.3710.5810.7910.86
Deferred Tax Assets2.173.584.2313.144.815.96
Other Assets0.460.420.420.340.320.17
Total Assets104.5297.7098.66109.0698.88100.85
Short Term Debt Incl. Current Port. of LT Debt0.000.000.001.390.000.00
Accounts Payable9.958.989.6310.8210.029.32
Other Current Liabilities7.936.327.517.978.696.54
Total Current Liabilities17.8715.3017.1420.1818.7215.86
Long Term Debt22.5023.2522.7723.0524.6930.45
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---8.50--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities40.3738.5539.9151.7343.4146.31
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity64.1559.1558.7557.3355.4754.53
Total Shareholders Equity64.1559.1558.7557.3355.4754.53
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity64.1559.1558.7557.3355.4754.53
Total Liabilities & Stockholders Equity104.5297.7098.66109.0698.88100.85
Book Value Per Share3.202.972.912.842.732.67
Tangible Book Value Per Share2.702.462.402.312.202.14
Full-Time Employees---473--
Price to Book Ratio4.713.253.173.293.882.37
Return on Assets9.288.617.806.035.414.84
Return on Equity15.7815.0313.8911.549.959.39
Return on Invested Capital3.643.921.252.532.823.06
Quick Ratio2.392.141.801.531.601.84
Current Ratio2.682.502.141.801.902.19

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income3.163.231.022.042.262.60
Depreciation3.123.183.253.353.283.34
Other Funds (Non Cash)1.751.491.650.550.81-0.09
Funds from Operations9.418.536.326.137.516.70
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.93-1.76-5.351.000.980.31
Cash from Operating Activities10.346.780.977.138.497.01
Capital Expenditures-0.07-0.09-0.16-0.13-0.08-0.22
Net Assets From Acquisitions0.000.000.000.000.00-1.41
Sale of Fixed Assets and Businesses0.270.430.580.730.850.97
Purchase or Sale of Investments-2.17-4.86-1.68-2.79-1.03-1.03
Purchase of Investments-2.17-4.86-1.68-2.79-1.03-1.03
Sale Or Maturity of Investments--0.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.97-4.52-1.26-2.19-0.25-1.69
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.53-4.15-0.79-1.38-2.57-3.73
Repurchase of Common Pref Stock-0.63-4.16-0.97-1.38-2.75-3.73
Sale of Common Pref Stock1.160.010.18-0.000.180.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.760.760.00-1.33-5.44-2.38
Change in Long Term Debt-0.760.760.00-1.33-5.44-2.38
Issuance of Long Term Debt3.097.506.146.768.5713.47
Reduction of Long Term Debt-3.85-6.75-6.14-8.08-14.00-15.85
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.23-3.40-0.79-2.70-8.01-6.11
Net Change in Cash8.14-1.14-1.082.230.23-0.79
Free Cash Flow10.276.690.816.998.416.79
Price to Free Cash Flow10.978.818.387.928.955.12

Revenue breakdown

Total Surgical & Medical Instruments & Apparatus revenue2024: 134.86M 2025: 143.44M
United States2024: 134.86M 2025: 143.44M
Consolidation, Policy2024: -7.25M 2025: -7.19M
Device Solutions2024: 61.74M 2025: 64.10M
Patient Services2024: 80.38M 2025: 86.53M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.63%0.7M18.8M137.00K
2026-10-154.33%0.8M18.8M139.33K
2026-09-304.60%0.9M18.8M143.83K
2026-09-154.32%0.8M18.8M186.68K
2026-08-314.01%0.8M18.8M189.42K
2026-08-143.90%0.7M18.8M212.36K
2026-07-314.38%0.8M17.8M223.63K
2026-07-154.51%0.8M18.1M220.83K
2026-06-304.95%0.9M18.1M209.54K
2026-06-150.75%0.1M18.1M157.60K
2026-05-290.92%0.2M18.1M157.43K
2026-05-150.85%0.2M18.1M141.84K
2026-04-301.17%0.2M18.2M119.73K
2026-04-151.17%0.2M18.2M123.37K
2026-03-311.19%0.2M18.2M133.57K
2026-03-130.94%0.2M18.2M132.97K
2026-02-270.61%0.1M18.2M128.52K
2026-02-130.74%0.1M18.3M131.58K
2026-01-300.65%0.1M18.3M141.12K
2026-01-150.94%0.2M18.3M145.89K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5011.7014.200.0018.3340.000.000.992-0.0170.001
call5.009.6011.100.008.2490.000.000.939-0.1150.003
call7.507.308.607.505.62216.001.000.903-0.1120.004
call10.004.806.003.303.6852.000.000.853-0.1010.005
call12.502.353.102.851.76589.0037.000.759-0.0940.007
call15.000.301.000.501.05119526.000.548-0.0730.009
call17.500.000.750.001.6950.000.000.330-0.0820.008
call20.000.000.750.002.3070.000.000.270-0.1010.008
call22.500.000.750.002.7930.000.000.238-0.1150.007
put2.500.001.650.005.9090.000.00-0.008-0.0170.001
put5.000.000.750.007.1690.000.00-0.061-0.1140.003
put7.500.000.750.484.8792.000.00-0.097-0.1110.004
put10.000.000.750.003.3040.000.00-0.147-0.1000.005
put12.500.000.900.050.84552.000.00-0.055-0.0130.003
put15.000.001.552.751.6931.000.00-0.452-0.0710.009
put17.501.502.750.001.1160.000.00-0.670-0.0800.008
put20.004.106.300.003.0310.000.00-0.730-0.0990.008
put22.506.408.000.002.5020.000.00-0.761-0.1120.007

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-098-KCurrent report2026-11-09SEC
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-09-178-KCurrent report2026-09-17SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-28SCHEDULE 13GSEC
2026-07-288-KCurrent report2026-07-28SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-16SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-16SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-16SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-16SEC
2026-05-188-KCurrent report2026-05-12SEC
2026-05-18S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-148-KCurrent report2026-05-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05131.47K400
2026-040000
2026-0318.91K100
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.7.86%
Minerva Advisors LLC6.68%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.4.14%
VANGUARD CAPITAL MANAGEMENT LLC3.92%
ACADIAN ASSET MANAGEMENT LLC3.77%
HEARTLAND ADVISORS INC3.51%
AMERICAN CENTURY COMPANIES INC3.34%
First Eagle Investment Management, LLC3.15%
DIMENSIONAL FUND ADVISORS LP3.05%
RENAISSANCE TECHNOLOGIES LLC2.69%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF3.71%
Heartland Value Fund3.51%
First Eagle Small Cap Opportunity Fund2.73%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.71%
iShares Russell 2000 ETF2.16%
VANGUARD EXTENDED MARKET INDEX FUND1.13%
DIAMOND HILL SMALL CAP FUND1.12%
Fidelity Small Cap Index Fund1.04%
TETON Westwood Mighty Mites Fund0.92%
North Star Micro Cap Fund0.91%

OakChart. INFU. Cached 15 minutes.